Clinical trial / 2009
Vitamin E maintained cognition in Alzheimer's patients who showed reduced oxidative stress, but was linked to worse cognitive decline in non-respondents.
Fifty-seven Alzheimer's disease patients were randomized to receive placebo or 800 IU of vitamin E daily for six months, with 33 finishing the trial. Among vitamin E-treated patients, respondents showed lower blood oxidized glutathione (GSSG) levels and maintained cognitive test scores. In non-respondents where oxidative stress was not prevented, cognition decreased sharply to levels lower than those taking placebo.
- Study type
- Randomized controlled trial
- Who was studied
- 57 Alzheimer's disease patients recruited, 33 completed
- What was measured
- Blood oxidized glutathione (GSSG) and cognitive test scores (MMSE, Blessed-Dementia Scale, Clock Drawing Test)
THE PAPER
Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.
Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, Viña J. J Alzheimers Dis, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.